Glover D D, Larsen B
Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown 26506-9186, USA.
Obstet Gynecol. 1998 Jan;91(1):115-8. doi: 10.1016/s0029-7844(97)00588-7.
To evaluate the purported association of antibiotic use and subsequent symptomatic Candida vaginitis among pregnant women.
Two hundred fifty obstetric patients were followed in a prospective, culture-based, longitudinal, and observational study from the first antepartum appointment through the postpartum visit at 6 weeks. All patients were cultured for yeast (Nickerson agar) initially. Patients with symptoms and microscopic evidence of vaginitis at the initial visit were followed through pregnancy but were not analyzed with asymptomatic individuals who had vaginal cultures for Candida at the first visit and at subsequent visits if they developed vulvovaginal symptoms. Patients were categorized as colonized or uncolonized on the basis of initial cultures and were evaluated at least monthly for antibiotic use and vaginal complaints. In addition, hospital records were reviewed after the final visit to document antibiotic use or vaginal infection.
Asymptomatically colonized patients were at a threefold greater risk of developing symptoms than were uncolonized patients (P < .001). Among women receiving antibiotics during pregnancy, 6.1% developed symptoms of Candida vaginitis compared with 15.6% of women who did not receive antibiotics. For the entire study population, 46% of the patients received at least one course of antibiotic therapy and 21% had multiple courses. Only three of the seven who became symptomatic with yeast vaginitis did so within 4 weeks of treatment. Many of the antibiotic regimens were prescribed by providers other than the obstetrician.
Antibiotic treatment during pregnancy was frequent in the study population, but was not associated with a significant risk of developing Candida vaginitis.
评估孕妇使用抗生素与随后发生症状性念珠菌性阴道炎之间的所谓关联。
在一项前瞻性、基于培养、纵向观察性研究中,对250名产科患者从首次产前检查直至产后6周随访。所有患者最初均进行酵母(尼克森琼脂)培养。初诊时有阴道炎症状及镜下证据的患者在孕期接受随访,但不与初诊时阴道念珠菌培养阳性且后续出现外阴阴道症状时才接受培养的无症状个体一同分析。根据初始培养结果将患者分为定植或未定植,并至少每月评估抗生素使用情况及阴道不适。此外,在最后一次随访后查阅医院记录,以记录抗生素使用情况或阴道感染情况。
无症状定植患者出现症状的风险是未定植患者的三倍(P <.001)。孕期接受抗生素治疗的女性中,6.1%出现念珠菌性阴道炎症状,而未接受抗生素治疗的女性中这一比例为15.6%。在整个研究人群中,46%的患者接受了至少一个疗程的抗生素治疗,21%接受了多个疗程。在出现酵母性阴道炎症状的7名患者中,只有3名在治疗后4周内出现症状。许多抗生素治疗方案是由产科医生以外的医护人员开具的。
在研究人群中,孕期抗生素治疗很常见,但与发生念珠菌性阴道炎的显著风险无关。